Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schaich

Showing results (361-370 of 421) with videos related to

Pageof 43
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 studyMarkus Schaich, Christoph Röllig, Silke Soucek, et al.
Lancet (London, England)|August 11, 2012
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised studyHannes Wandt, Kerstin Schaefer-Eckart, Knut Wendelin, et al.
American Journal of Human Genetics|August 21, 2012
A nonsense mutation in PDE6H causes autosomal-recessive incomplete achromatopsiaSusanne Kohl, Frauke Coppieters, Françoise Meire, et al.
Plos One|January 10, 2013
Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot studyUtz Krug, Anja Koschmieder, Daniela Schwammbach, et al.
Blood|April 12, 2012
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantationNicola Gökbuget, Daniel Stanze, Joachim Beck, et al.
Haematologica|February 22, 2024
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemiaSonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Physical Review Letters|November 10, 2015
Detecting Stealth Dark Matter Directly through Electromagnetic PolarizabilityT Appelquist, E Berkowitz, R C Brower, et al.
Research Square|December 3, 2025
Molecular basis for CSB stimulation of the SNM1A DNA repair nucleaseRebecca Roddan, Matthew A Schaich, William J Nathan, et al.
Lancet (London, England)|December 7, 2010
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomesUtz Krug, Christoph Röllig, Anja Koschmieder, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 3, 2021
Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of AtherosclerosisChristopher L Schaich, Joseph Yeboah, Mark A Espeland, et al.
Pageof 43

Showing results (361-370 of 421) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 studyMarkus Schaich, Christoph Röllig, Silke Soucek, et al.
Lancet (London, England)|August 11, 2012
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised studyHannes Wandt, Kerstin Schaefer-Eckart, Knut Wendelin, et al.
American Journal of Human Genetics|August 21, 2012
A nonsense mutation in PDE6H causes autosomal-recessive incomplete achromatopsiaSusanne Kohl, Frauke Coppieters, Françoise Meire, et al.
Plos One|January 10, 2013
Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot studyUtz Krug, Anja Koschmieder, Daniela Schwammbach, et al.
Blood|April 12, 2012
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantationNicola Gökbuget, Daniel Stanze, Joachim Beck, et al.
Haematologica|February 22, 2024
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemiaSonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Physical Review Letters|November 10, 2015
Detecting Stealth Dark Matter Directly through Electromagnetic PolarizabilityT Appelquist, E Berkowitz, R C Brower, et al.
Research Square|December 3, 2025
Molecular basis for CSB stimulation of the SNM1A DNA repair nucleaseRebecca Roddan, Matthew A Schaich, William J Nathan, et al.
Lancet (London, England)|December 7, 2010
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomesUtz Krug, Christoph Röllig, Anja Koschmieder, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 3, 2021
Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of AtherosclerosisChristopher L Schaich, Joseph Yeboah, Mark A Espeland, et al.
Pageof 43